Akome Biotech Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Akome Biotech General Information
Description
Developer of psychedelic-based pharmaceuticals specializing aimed at treating rare diseases and mental disorders. The company makes drugs for the treatment of cluster headaches, Alzheimer's Disease, and depression, thereby providing patients suffering from stroke and neurological illnesses with effective and safe solutions.
Contact Information
Website
www.akomebiotech.comCorporate Office
- Vancouver, British Columbia
- Canada
Corporate Office
- Vancouver, British Columbia
- Canada
Akome Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Akome Biotech FAQs
-
When was Akome Biotech founded?
Akome Biotech was founded in 2020.
-
Where is Akome Biotech headquartered?
Akome Biotech is headquartered in Vancouver, Canada.
-
What industry is Akome Biotech in?
Akome Biotech’s primary industry is Drug Discovery.
-
Is Akome Biotech a private or public company?
Akome Biotech is a Private company.
-
What is Akome Biotech’s current revenue?
The current revenue for Akome Biotech is .
-
When was Akome Biotech acquired?
Akome Biotech was acquired on 05-May-2021.
-
Who acquired Akome Biotech?
Akome Biotech was acquired by Core One Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process